Zobrazeno 1 - 10
of 159
pro vyhledávání: '"EIICHIRO TOMINAGA"'
Autor:
Yuya Nogami, Yusuke Kobayashi, Kosuke Tsuji, Megumi Yokota, Hiroshi Nishio, Masaru Nakamura, Wataru Yamagami, Tohru Morisada, Eiichiro Tominaga, Kouji Banno, Daisuke Aoki
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-7 (2020)
Abstract Background The number of cases of novel coronavirus disease 2019 (COVID-19) in Japan have risen since the first case was reported on January 24, 2020, and 6225 infections have been reported as of June 30, 2020. On April 8, 2020, our hospital
Externí odkaz:
https://doaj.org/article/160d25078dc64265b0d422cf2e765e49
Autor:
Yuya Nogami, Kouji Banno, Masataka Adachi, Haruko Kunitomi, Yusuke Kobayashi, Eiichiro Tominaga, Daisuke Aoki
Publikováno v:
Infectious Diseases in Obstetrics and Gynecology, Vol 2019 (2019)
Background. Surgery for gynecologic cancer with lymphadenectomy and pelvic radiotherapy can produce lymphoceles that sometimes complicate with infection, resulting in abscesses. The true pathogenic bacteria of abscesses are not always found because o
Externí odkaz:
https://doaj.org/article/11e25b9c12004a1bafa5b8a4bc8428d5
Autor:
Moito Iijima, Shigenori Hayashi, Yusuke Kobayashi, Kosuke Tsuji, Eiichiro Tominaga, Kouji Banno, Daisuke Aoki
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2019 (2019)
Pelvic inflammatory disease (PID) sometimes develops after intrauterine insemination (IUI). We herein present a case of PID which developed after IUI performed after abdominal modified radical trachelectomy (AmRT) and was treated with laparoscopic su
Externí odkaz:
https://doaj.org/article/dfce4e2c6ce74b04a261a5eaa58554ae
Publikováno v:
Experimental and Therapeutic Medicine. 25
Publikováno v:
Journal of Gynecologic Oncology. Mar2018, Vol. 29 Issue 2, p1-5. 5p.
Autor:
Shimpei Nagai, Eiichiro Tominaga, Kouji Banno, Shigenori Hayashi, Tatsuya Suzuki, Daisuke Aoki, Yusuke Kobayashi, Shigeo Okuda, Takashi Takeda, Kosuke Tsuji
Publikováno v:
International Journal of Gynaecology and Obstetrics
Objective To optimize prediction for intestinal invasion of epithelial ovarian cancer. It is important to achieve debulking surgery to improve prognosis in ovarian cancer; intestinal resection is adopted if the cancer is invaded and resectable, but t
Autor:
Shigenori Hayashi, Daisuke Aoki, Yusuke Kobayashi, Fumio Kataoka, Hiroyuki Nomura, Tatsuyuki Chiyoda, Kouji Banno, Eiichiro Tominaga, Masaru Nakamura, Kensuke Sakai, Hiroshi Nishio, Wataru Yamagami
Publikováno v:
International Journal of Gynecology & Obstetrics. 153:438-442
OBJECTIVE To determine the efficacy of drainage following pelvic lymph node (PLN) dissection, especially for cases involving laparoscopic surgery. METHODS In this retrospective study, 368 patients with malignant gynecological tumors who underwent sys
Autor:
Masaru Nakamura, Shimpei Nagai, Kosuke Tsuji, Kouji Banno, Iori Kisu, Wataru Yamagami, Yusuke Matoba, Eiichiro Tominaga, Daisuke Aoki, Miho Kawaida, Yusuke Kobayashi
Publikováno v:
Journal of Minimally Invasive Gynecology. 27:1087-1094
To examine the diagnostic accuracy of hysteroscopic photodynamic diagnosis (PDD) using 5-aminolevulinic acid (5ALA) in patients with endometrial cancer and premalignant atypical endometrial hyperplasia.A single-center, open-label, exploratory interve
Autor:
Kouji Banno, Miho Iida, Megumi Yanokura, Haruko Irie, Kenta Masuda, Yusuke Kobayashi, Eiichiro Tominaga, Daisuke Aoki
Publikováno v:
The Scientific World Journal, Vol 2015 (2015)
The goals of drug repositioning are to find a new pharmacological effect of a drug for which human safety and pharmacokinetics are established and to expand the therapeutic range of the drug to another disease. Such drug discovery can be performed at
Externí odkaz:
https://doaj.org/article/6287041168274984a798f597261dea0d
Autor:
Kanako Nakamura, Moito Iijima, Mayuka Anko, Takashi Takeda, Haruko Kunitomi, Eiichiro Tominaga, Takayuki Takahashi, Shimpei Nagai, Daisuke Aoki, Yusuke Kobayashi, Kouji Banno, Yusuke Matoba, Kosuke Tsuji
Publikováno v:
European Journal of Cancer Prevention. 28:562-567
Novel pharmacological therapies are in development for cancer, ranging from conventional chemotherapeutic drugs to molecular targeted drugs, antibody-based drugs, and immune checkpoint inhibitors, which are developed using new technologies. However,